Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus (NCT01510067)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
• University of Texas Southwestern — Dallas, Texas

📞 Contact the Study Coordinator

Phone: (215) 615-2940

Email: werth@pennmedicine.upenn.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cutaneous Lupus Erythematosus (CLE)

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus — Beverly Hills, California
• A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus — Philadelphia, Pennsylvania

Explore by condition: All Cutaneous Lupus Erythematosus (CLE) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.